Get started
Author

Vivek Pandav

Observed institution: Mayo Clinic in Florida
OpenAlex ID: A5108841018
Retrospective analysis of the multikinase inhibitor (MKI) pazopanib in differentiated thyroid carcinoma (DTC) in the beyond-first-line setting.
2023 · Jyothik Varun Inampudi, Himil Mahadevia, et al. · Journal of Clinical Oncology · 2
Incidence of additional primary malignancies in patients with malignant peritoneal mesothelioma.
2023 · Vivek Pandav, Jaydeepbhai Patel, et al. · Journal of Clinical Oncology · 1
PDF
Incidence of other multiple primary malignancies in patients with adrenocortical carcinoma.
2023 · Hiren Koshiya, Vivek Pandav, et al. · Journal of Clinical Oncology
Works count: 3
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type